The Portrait Flex assay provides tailored analyses performed as a service by ANGLE's Onc-ADaPT™ laboratoriesGUILDFORD, SURREY / ACCESSWIRE / September 4, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), ...
GUILDFORD, SURREY / ACCESSWIRE / May 22, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company announces that Garth Selvey has informed the Board of his intention to retire ...
GUILDFORD, SURREY / ACCESS Newswire / June 17, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon the publication of this ...
GUILDFORD, SURREY / ACCESS Newswire / October 8, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a global precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions ...
BREAKTHROUGH RESEARCH DEMONSTRATES A PARSORTIX TEST COULD AVOID UNNECESSARY PROSTATE BIOPSIES Barts Cancer Institute demonstrates capability of Parsortix system to detect clinically significant ...
Full Class II De Novo FDA Submission seeking clearance of the Parsortix system for metastatic breast cancer has successfully completed FDA administrative review ANGLE believes that the earliest ...
GUILDFORD, SURREY / ACCESS Newswire / September 9, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZeneca Results of Eisai Phase 2 pilot study supports the ...
PHILADELPHIA--(BUSINESS WIRE)--ANGLE plc (AIM:AGL OTCQX:ANPCY), the UK-based medical diagnostics company with pioneering products for cancer diagnostics and fetal health, announces a poster ...
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that further to the announcement of 30 October 2017 and General Admission earlier today, the Fundraising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results